Genmab — April 2023

Bulder

Kunne se ud til, at Bidens valgtale også påvirker genmab efter us åbning.

Bulder

Novo har fået på hatten hele dagen. Forstærkes nu.

E_L

ASCO abstract titles are out for those interested https://meetings.asco.org/abstracts-presentations

Bulder

Us healthcare er mørkerødt sammen med NBI.

Teller

Nu vil det Biden taler om jo næppe ramme nye midler... Det har altid været "hverdags medicin" der har stået for skud

Bulder

Jeg heller ikke så meget på, at genmab bliver ramt (eller Novo for den sags skyld), men det får altid en kurseffekt, hver gang emnet kommer på bane. Det er mere valgflæsk end realiteter.

Bulder

… tror …

JKY_VH

Ja det er set før især når Bernie Sanders har givet den gas.

bikube

Bernie har jo lige meddelt, at han ikke stiller op til valget denne gang, men han støtter Bidens kandidatur.

JKY_VH

I know, men det var hans tidligere retorik jeg referede til;-)

Helge_LarsenPI-redaktør

Godmorgen

bibob

God morgen.

Stroka

God morgen

E_L

I don't the full abstract was posted yet: Tisotumab vedotin (TV) in squamous cell carcinoma of head and neck (SCCHN): interim analysis from innovaTV 207 https://aacrjournals.org/cancerres/article/83/8_Supplement/CT164/725551

E_L

i wonder if they will also try this dose adjustment now in the cervical cancer population. not sure how difficult this is in an already approved dosing regimen

E_L

Seagen reports later today. possibly the last time before pfizer takes over? See if they are on track for more data updates in H2, as anticipated

E_L

sanofi Q1 23 - Sarclisa
sales were €87 million -that still doesn't look like huge competition
so far

Bulder

Still not sc. As far as I can see. Study started last year. https://clinicaltrials.gov/ct2/show/NCT05405166

E_L

no; they have it in their Expected submission timeline in '2025 and beyond' https://www.sanofi.com/dam/jcr:a47dcb49-3067-44bc-9cd1-dc1fd0094b66/2023_04_27_Sanofi_Q1_2023_Results_Presentation.pdf

Bulder

Oh, by that time dara patent has run out almost.